This inventor holds 31 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Cancer Therapeutics. Top assignees: Farmitalia Carlo Erba, Farmitalia Carlo Erba S.r.l., Pharmacia & Upjohn. Active years: 1978-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Milano, IT (1990)
- Milan, IT (1978 - 2012)
Company Filing History:
10 out of 208 
10 out of 140 
4 out of 117 
Years Active: 1978-2012
Areas of Expertise:
Title: **Francesco Angelucci: Innovator in Kinase Inhibition**
Introduction
Francesco Angelucci, based in Milan, Italy, is a distinguished inventor with an impressive portfolio of 31 patents. His work focuses on advancements in pharmaceuticals, particularly in the development of compounds that address critical health concerns, such as cancer and neurodegenerative disorders. His innovative contributions have made a significant impact on the field of medical research and treatment.
Latest Patents
Among Francesco Angelucci's latest patents are "Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them." This invention details compounds that are pyrrolo[2,3-b]pyridine derivatives or their pharmaceutically acceptable salts, along with their preparation processes. These compounds are notable for their potential use in treating diseases associated with altered protein kinase activities, including cancer, Alzheimer's disease, and various viral and autoimmune disorders. Additionally, his patents outline a process under SPS conditions for synthesizing these compounds, contributing to the creation of a chemical library that offers a multitude of variants.
Career Highlights
Francesco Angelucci has held significant roles in notable companies such as Farmitalia Carlo Erba S.r.l. and Farmitalia Carlo Erba S.p.a. His experience in these organizations has played a crucial role in honing his expertise in pharmaceutical innovations and patent development. His contributions have led to advancements that are vital for both therapeutic applications and the broader scientific community.
Collaborations
Throughout his career, Francesco has collaborated with esteemed colleagues, including Antonino Suarato and Federico Maria Arcamone. These partnerships have fostered an environment of innovation and have further propelled their shared goal of developing effective pharmaceuticals.
Conclusion
Francesco Angelucci stands out as a leading inventor in the pharmaceutical field. His dedication to developing novel kinase inhibitors and his collaborative work with other prominent scientists emphasize his commitment to tackling some of the most pressing health challenges of our time. With a total of 31 patents to his name, Angelucci continues to inspire future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile